Unifying CRM and EWOC designs for phase I cancer clinical trials (Q1007501)

From MaRDI portal
Revision as of 16:58, 10 July 2023 by Importer (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Unifying CRM and EWOC designs for phase I cancer clinical trials
scientific article

    Statements

    Unifying CRM and EWOC designs for phase I cancer clinical trials (English)
    0 references
    0 references
    0 references
    0 references
    20 March 2009
    0 references
    phase I cancer clinical trial
    0 references
    maximum tolerated dose
    0 references
    dose-limiting toxicity
    0 references
    continual reassessment method
    0 references
    escalation with overdose control
    0 references

    Identifiers